Werbung
Werbung

GKOS

GKOS logo

Glaukos Corporation

113.73
USD
Gesponsert
+1.75
+1.56%
07. Jan., 16:00 UTC -5
Geschlossen
exchange

Vor-Markt

113.80

+0.06
+0.06%

GKOS Ergebnisberichte

Positives Überraschungsverhältnis

GKOS übertreffen die 28 der letzten 40Schätzungen.

70%

Nächster Bericht

Datum des nächsten Berichts
18. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$132.09M
/
-$0.21
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-1.09%
/
+31.25%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+25.20%
/
-47.50%

Glaukos Corporation earnings per share and revenue

On 29. Okt. 2025, GKOS reported earnings of -0.16 USD per share (EPS) for Q3 25, beating the estimate of -0.26 USD, resulting in a 39.14% surprise. Revenue reached 133.54 million, compared to an expected 124.99 million, with a 6.84% difference. The market reacted with a +13.89% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 132.09 million USD, implying an increase of 31.25% EPS, and decrease of -1.09% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, Glaukos Corporation reported EPS of -$0.16, beating estimates by 39.14%, and revenue of $133.54M, 6.84% above expectations.
The stock price moved up 13.89%, changed from $77.09 before the earnings release to $87.80 the day after.
The next earning report is scheduled for 18. Feb. 2026.
Based on 18 analysts, Glaukos Corporation is expected to report EPS of -$0.21 and revenue of $132.09M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung